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A method for the production of plasmids giving different levels of expression of ovine growth hormone (oGH) variants 
in E. coli is described. The cDNA sequence coding for mature oGH was inserted into the multiple cloning site of plasmid 
pUC8 and random deletions were then introduced 3' to the initiation codon. Clones producing GH (with varying N-ter- 
minal extensions) were identified byimmunological screening. Levels of expression of GH-related protein, measured by 
immunoassay or on SDS-polyacrylamide g ls, varied from over 20~ to less than 0.05% of total cell protein. The coding 
sequence of plasmid pOGHel01, giving very high expression of variant oGH 1, was determined. 
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1. INTRODUCTION 
A number of authors have reported problems in 
obtaining high level expression of GH in bacterial 
systems. Thus, we have previously found only low 
expression of the cDNA sequence coding for ovine 
(sheep) preGH in E. coli [1] and various authors 
have reported that the natural sequence coding for 
the mature form of bGH (which is very similar to 
that of oGH [2]) is not well expressed in E. coli 
[3-5]. Alterations in the sequence coding for the N- 
terminus of bGH [3,4], or insertion of additional 
nucleotides 3' to the AUG initiation site, forming 
a 2-cistron expression system [5], increased expres- 
sion up to 50-fold. Alteration of 5' -non-coding se- 
quences increased expression of porcine GH [6]. 
These various tudies indicate that the sequence 5' 
and 3' to the AUG initiation site has a marked ef- 
fect on the efficiency of expression of GH. The 
Correspondence address: O.C. Wallis, Biochemistry Labora- 
tory, School of Biological Sciences, University of Sussex, 
Falmer, Brighton BN1 9QG, England 
Abbreviations: GH, growth hormone (oGH, ovine GH; bGH, 
bovine GH); IPTG, isopropyl ~-D-thiogalactopyranoside 
reasons for this are not clear; formation of secon- 
dary structure in mRNA may be important, but 
cannot explain the observations completely. 
In this paper we describe a new approach to the 
problem of obtaining high level expression of GH 
in E. coli. Rather than studying the effect of in- 
troducing a limited number of specific hanges, we 
have produced a range of initially unspecified 
alterations in theregion 3' to the initiation codon 
of a gene comprising the mature oGH coding se- 
quence linked to a short leader sequence, in a 
pUCS-based plasmid [7]. The effect of a large 
number of sequence changes on expression effi- 
ciency could thus be studied rapidly, and those giv- 
ing high expression could be identified and char- 
acterized. A preliminary account of this work has 
been presented [8]. 
2. METHODS 
2.1. Bacterial strains, plasmids and enzymes 
E. coil strains JM101 and HBl01 F' were used for expression 
and sequencing, respectively. Initial plasmids were pUC8 [7], 
pOGH4 (a plasmid containing the cDNA sequence ncoding 
preoGH [2]) and pJBS633 [9]. Media were those described by 
Miller [10] with the addition of 50/zg ampicillin per ml when 
bacteria contained pUC8-based plasmids. 
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DNA modifying enzymes and dideoxynucleotides w re ob- 
tained from BCL (Lewes, England), Gibco BRL (Paisley, 
Strathclyde, Scotland) or Amersham International (Amersham, 
Bucks, England) and were used according to the manufacturers' 
instructions. 
2.2. Construction of expression plasmids 
The 635 base-pair fragment, obtained by cutting pOGH4 with 
HaelI and HindIII and containing the coding sequence for 
mature oGH (fig. 1), was ligated into the multiple cloning site of 
pUC8 between the BamHI and HindlII sites after conversion of 
BamHI and HaeII sites to blunt ends [11]. After transformation 
of E. coli JM101 [12] the ampicillin-resistant colonies were 
screened for GH production (see below). Plasmid DNA from 
these colonies, prepared by the alkali ysis method [1.1], was 
treated with EcoRI, BamHI or HindIII. Plasmid DNA from one 
transformant (pOGHel00), after treatment with EcoRI, was 
subjected to brief digestion with exonuclease Bal31, followed by 
treatment with the Klenow fragment of DNA polymerase I to
give blunt ends, before religation with T4 DNA ligase. GH- 
producing colonies were identified after transformation of E. 
coli JMI01 with the ligation mixture. The construction pro- 
cedure is summarized in fig. 1. 
2.3. Screening of clones for GH production 
Colonies were grown overnight on nitrocellulose discs 
(Schleicher and Schuell, D-3354 Dassel, FRG) on B agar plates 
[10] and then induced for 4-6 h on B agar plates containing 160 
/~g IPTG/ml. Bacteria were lysed and proteins bound to the 
nitrocellulose [13]. Colonies containing GH-related protein 
were identified by their red/brown colour after treatment with 
a rabbit polyclonal antibody to bGH followed by donkey anti- 
rabbit IgG-peroxidase conjugate and then 3,3'-diaminobenzi- 
dine/H202. Further screening was carried out after growth of
bacteria in 2TY medium with vigorous aeration at 37°C. When 
the absorbance of the culture at600 nm reached 0.6, IPTG (160 
/zg/ml) was added as inducer. After the induction period 
bacteria were harvested by centrifugation, washed and 
resuspended in 0.1 M NaHCO3/NaOH, pH 8.9, broken by 
sonication for 30 s in an MSE 150w sonicator (amplitude 20) and 
separated into supernatant and pellet fractions bycentrifuga- 
tion for 2 rain at 11 000 x g. Proteins inthe pellet fraction or 
in the unfractionated sonicate were analysed by SDS- 
polyacrylamide g l electrophoresis (12.5%, w/v, acrylamide) 
[14]. Gels were stained with Kenacid blue and scanned using an
LKB Ultroscan XL laser densitometer. P otein bands on gels 
were subjected to Western blotting and GH-related proteins 
were detected using antibody to bGH as described above. GH- 
related proteins  the supernatant fraction were determined by 
radioimmunoassay [15]. 
2.4. Sequencing of plasmid DNA 
DNA from one expression plasmid was digested with BanII 
and PvuII and the BanlI ends converted o blunt ends with T4 
DNA polymerase [11]. The sequence of those fragments con- 
taining the coding sequence for oGHand the pUC8 derived se- 
quence around the initiation codon was determined by the chain 
termination procedure [16] after insertion of the fragments be- 
tween the EcoRV and PvuII sites of plasmid pJBS633 [9]. 
3. RESULTS AND DISCUSSION 
The HaeI I / I t ind I I I  fragment of pOGH4 was 
ligated between the BamHI  and HindI I I  sites of 
plasmid pUC8 in order to insert he DNA sequence 
coding for mature oGH (without signal peptide) 
after the init iation codon for 13-galactosidase 
(fig. 1). After t ransformat ion f E. coli JM101 with 
the l igation products only 8 transformants were ob- 
tained and none produced detectable amounts of 
GH when screened on nitrocellulose discs. Treat- 
ent  of plasmid DNA from the transformants with 
EcoRI ,  BamHI  or HindI I I  showed that all contain- 
ed EcoRI  and HindI I I  sites but were not digested 
by BamHI .  (It was expected that a BamHI  site 
would be reformed after l igation, giving an in- 
frame fusion, but this did not occur). 
DNA from one transformant was treated with 
EcoRI  and then for 30 s-1 min with exonuclease 
Bal31 followed by religation. This procedure 
should produce a range of short deletions around 
the EcoRI  site. Transformat ion of E. coli JM101 
with the l igation products led to the production of 
over 2000 transformed colonies. As the deletions 
would be expected to be random about the EcoRI  
site only one third of the resulting plasmids would 
be expected to contain the oGH sequence in the 
correct reading frame for expression. 19 of the first 
92 colonies screened for GH product ion on 
nitrocellulose discs gave a positive result and these 
were studied further after growth in 2TY medium. 
Table 1 shows the 'GH'  content of the soluble frac- 
t ion from 10 of these transformants sonicated after 
2.25 to 21.5 h induction with IPTG.  The concentra- 
t ion of 'GH '  in these supernatant fractions cor- 
responded to less than 0.05°70 of the total soluble 
protein in all cases. Analysis of the pellet fraction 
on SDS-PAGE after 21.5 h induct ion showed that 
a protein band was present in some transformants 
which was absent from the pellets of control 
bacteria (fig.2). There were large differences be- 
tween the clones in the level of expression of these 
extra bands: in two clones (2 and 6) the band com- 
prised over 40070 of the protein i  the pellet fraction 
while in others much lower levels were found. 
Western blotting demonstrated that the protein in 
these bands was GH-related, specifically binding 
polyclonal ant ibody raised against bGH.  When the 
total proteins from clones 2 or 6 were run on SDS- 
PAGE the extra bands, which had an apparent Mr 
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Fig. 1. Scheme for construction f expression plasmids. (*~'~) Bases derived from oGH cDNA. Only those restriction sites used in 
construction f sequencing or expression plasmids are shown, lacpo, lac promoter. 
close to that of authentic bGH, were found to con- 
stitute over 20°7o of the bacterial protein. Com- 
parison of the results hown in table 1 and fig.2 in- 
dicates that when high expression occurs most of 
the GH-like protein is present in an insoluble form, 
presumably as inclusion granules. 
Initially clones 6 (fig.2) containing the plasmid 
designated pOGHel01 and producing GH-related 
protein oGH1 was selected for further study. The 
sequence of bases coding for the N-terminus of 
oGHI,  determined by sequencing the appropriate 
Pvu l I /Ban l I  fragment from pOGHel01 (see fig. 1), 
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(h) Clone number 
JM101 I 2 3 4 5 6 7 8 9 l0 
2.25 0 a 0.64 0.44 0.03 0.82 0 0 0 0.54 0.27 0.03 
3.7 0 1.4 1.4 0.29 0.13 0.07 2.6 0 2.0 0.87 0.11 
21.5 0 2.5 1.0 0 0 0 1.8 0.10 1.0 0.34 0 
a A figure of 0 in the table indicates that no significant concentration f GH could be detected under the 
conditions of the assay 
All clones were grown in 2TY medium and induced by addition of IPTG when An0o n• reached 0.6. 
Bacteria were broken by sonication after harvesting and the GH content of the 11 000 x g supernatant 
was determined by radioimmunoassay using bGH as standard. The results are expressed as microgram 
GH in bacterial supernatant per 100 ml culture 
1 2 34  5 C M 6 7 8 9 10 
Fig.2. SDS-polyacrylamide gelelectrophoresis on proteins from E. coli clones. Pellet fractions from broken induced bacteria were run 
on 12.5°/0 gels, as described insection 2. C, control bacteria (no expression plasmid); lanes 1-10, bacteria clone umbers (+ expression 
plasmids); M, bGH (Mr 21 800) and ovine prolactin (Mr 22 700) markers. 
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ATG ACC ATG ATT  ACGSAAT 
BamHI  
Tcc cGG ~A 
Thr  Met  I le  Thr  Asn  Ser  Arg  Gly  
< 8 -ga lac tos idase  >< MCS 
b lunt  
Hae I I  
end l igat ion  
TTC CCA GCC ATG TCC TTG .... 
Phe Pro  A la  Met  Ser  Leu  .... 
< oGH .... 
pOGHe i 01 
ATG ACC ATG ATT  ACG AAT TCC GGG GAC TTC CCA GCC ATG TCC TTG .... 
Thr  Met  I le Thr  Asn  Ser  G ly  Asp  Phe Pro  A la  Met  Ser  Leu  .... 
< 8 -ga lac tos idase  >< l ink  >< oGH .... 
Fig.3. Nucleotide sequences and corresponding amino acid sequences in pOOHel01 and its parent plasmids (pUC8 and pOGH4). Part 
of the sequences for pUC8 and pOGH4 show the expected s quences of the 3'- and 5'-ends to be ligated to give plasmid pOGHel00 
(see fig. 1). Bases in italics are missing fromthe final pOGHel01 sequence. MCS, multiple cloning site. The nucleotide sequence in 
pOGHel01, corresponding to the codons for the N-terminus of oGHI, was determined as described in the text. 
is shown in fig.3 together with the corresponding 
amino acid sequence. The remainder of the bases 
coding for oGH1 were found to correspond to the 
sequence previously determined for oGH [2]. 
Codons for the N-terminus of B-galactosidase 
(derived from pUC8) up to and including the 
EcoRI site are complete xcept that one base has 
been deleted at this point (presumbly by the Bal31 
treatment). A further two bases have been lost at 
the pUC8/pOGH4 junction; the explanation for 
this is not clear but it explains the failure to obtain 
expression with the initial fusion plasmid since the 
oGH sequence would not be in the correct reading 
frame in this construct. The sequence in 
pOGHel01 clearly allows a very high level of ex- 
pression of the GH-related fusion protein. A com- 
parison of this sequence with at in the other ex- 
pression plasmids showing high or low expression 
may allow identification of features for efficient 
protein synthesis in this system. Further screening 
of the clones obtained in this study and identifica- 
tion of those expressing GH variants in high yield 
are in progress. 
The procedure described here provides a promis- 
ing method for generating large numbers of expres- 
sion plasmids and selecting those which give high 
yields of GH variants. The approach may also be 
of value in other expression systems. The high level 
of  expression of oGH1 in induced bacteria contain- 
ing plasmid pOGHel01 allows production of large 
amounts of this protein for further study. The 
purification of oGH1 in high yield and a study of 
its properties will be reported separately. 
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